# A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-i-ii-evaluation-of-veliparib-nsc-737664-topotecan-and-filgrastim-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Charles A. Kunos,Wei Deng,Dawn Dawson,Jayanthi Lea,Kristine Zanotti,Heidi J. Gray,David Bender,Perry P. Guaglianone,Jori S. Carter,Kathleen N. Moore |
| Citations | 66 |
| DOI | 10.1097/igc.0000000000000380 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/4336206 |
| OpenAlex ID | https://openalex.org/W2329531543 |
| PMID | 25594147 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Wei Deng](https://scholariq.org/researchers/wei-deng/)

## Paper journal

- [International Journal of Gynecological Cancer](https://scholariq.org/journals/international-journal-of-gynecological-cancer/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.